Fast Results

Human Immunodeficiency Virus 1/2/O Antibody (HIV 1/2/O Ab) Triline Rapid Test

Rapid detection of HIV-1/2/O antibodies in minutes for early HIV diagnosis and management.

CE Certified
ISO 13485
Main image of Human Immunodeficiency Virus 1/2/O Antibody (HIV 1/2/O Ab) Triline Rapid Test

Why Choose reOpenTest Infectious Disease Kits?

Our tests are engineered for accuracy, reliability, and ease of use, ensuring confidence in every result.

Comprehensive HIV Detection

Detects antibodies to HIV-1, HIV-2, and HIV-O subtypes.

Rapid Results

Provides results in 15-20 minutes for timely intervention.

Versatile Sample Types

Suitable for use with whole blood, serum, or plasma samples.

Product Overview

The Human Immunodeficiency Virus 1/2/O Antibody (HIV 1/2/O Ab) Triline Rapid Test is an in vitro diagnostic test for the detection of antibodies to HIV-1, HIV-2, and HIV-O in human serum, plasma, or whole blood. This test is intended for professional use to aid in the diagnosis of HIV infection.

Technical Specifications

Detection Target HIV 1/2/O Antibodies
Sample Type Whole blood, Serum, Plasma
Methodology Immunochromatography
Detection Range Qualitative (Positive/Negative)
Reaction Time 15-20 minutes
Storage Conditions 2-30u00b0C
Shelf Life 24 months

Procedure & Interpretation

Step-by-Step Procedure

  1. Collect a whole blood, serum, or plasma sample.
  2. Apply the sample to the test device.
  3. Add the provided buffer solution.
  4. Read the results after 15-20 minutes.
  5. Interpret the results based on the appearance of control and test lines.

Result Interpretation

Positive Result
Positive: The presence of control and two or more test lines indicates a positive result for HIV-1/2/O antibodies.
Negative Result
Negative: The presence of only the control line indicates a negative result.
Invalid Result
Invalid: If the control line does not appear, the test is invalid and should be repeated.

Frequently Asked Questions

Early detection of HIV infection allows for prompt initiation of antiretroviral therapy, improving patient outcomes and reducing transmission risk.

The rapid test provides faster results and requires minimal equipment, making it suitable for point-of-care settings, while ELISA assays are more sensitive and quantitative.

Store the test kit at 2-30u00b0C (36-86u00b0F) and protect it from freezing. Do not use the test after the expiration date.

Technical Documents

Download product inserts and brochures for detailed information.

No technical documents are available at this time. Please check back soon.

Partner with reOpenTest

Provide your clients and patients with reliable diagnostic solutions.
Contact us today for bulk pricing and distribution opportunities.

Become a Distributor